Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04957355 · ClinicalTrials.gov registry record · NA

Effect of NMES on Balance and Fall Risk in Chronic Stroke

A NA study of Chronic Stroke, sponsored by University of Illinois at Chicago.

Recruiting
Registry status
NA
Development phase
20
Enrollment target
1
Study location

NCT04957355: Recruiting NA study of Chronic Stroke, sponsored by University of Illinois at Chicago.

NCT04957355 is a NA study of Chronic Stroke that is actively recruiting participants, run by University of Illinois at Chicago. The registered enrollment target is 20 participants, below the 43-participant average among 20 other Chronic Stroke trials with a reported enrollment target (53% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04957355, a NA study of Chronic Stroke, is actively recruiting participants, sponsored by University of Illinois at Chicago.

RECRUITING
Registry status
NA
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

The aim of this study is to describe the effect of neuromuscular electrical stimulation (NMES) in the form of functional electrical stimulation (FES) applied to different lower limb muscles on reactive balance and gait performance in stroke participants. Methods: Twenty individuals with chronic stroke will be asked to perform an experimental protocol that includes a postural disturbance in the form of a slip- or trip-like perturbation and a standardized walking test in both laboratory and outdoor environments with and without FES applied to different lower limb muscles of the paretic leg. FES will be applied using an advanced software that is able to synchronize muscle activation with the time of perturbation onset and according to the phases of gait. This project design aims to examine whether a specific pattern of lower limb muscle stimulation could improve the kinematic and behavioral responses during reactive balance following slip- and trip-like perturbations. Additionally, the project aims to see if the kinematic and spatio-temporal gait parameters can be modified during a standardized walking test under different sensory and environmental conditions.

Primary Outcome

The outcome of a perturbation trial is dichotomous with #1 being a fall, which is assigned if the force detected by the load-cell exceeded 30% of the participant's body weight after perturbation or if the researcher assists the participant to attain a standing position following perturbation. Otherwise, the outcome is regarded as a non-fall (#0). Laboratory falls are reported in percentage (%), defined as the number of falls experienced during perturbation trials related to the total number of p

Conditions Studied

Interventions

  • DEVICE Neuromuscular electrical stimulation (NMES) or Functional electrical stimulation (FES)

Study Locations (1)

Illinois

  • University of Illinois at Chicago - Chicago

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2021-05-15
Est. Completion 2025-11-30
Phase NA
University of Illinois at Chicago

430 total trials

What NCT04957355 shows while recruiting

NCT04957355 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 43-participant average among 20 other Chronic Stroke trials with a reported enrollment target (53% lower).

The record links to 1 condition, with Chronic Stroke appearing as the primary indexed condition, and to 1 intervention - of which Neuromuscular electrical stimulation (NMES) or Functional electrical stimulation (FES) is the first listed.

NCT04957355 reports a single indexed study location in Illinois.

Frequently Asked Questions

What is clinical trial NCT04957355 about?

NCT04957355 is a clinical study titled "Effect of NMES on Balance and Fall Risk in Chronic Stroke". The aim of this study is to describe the effect of neuromuscular electrical stimulation (NMES) in the form of functional electrical stimulation (FES) applied to different lower limb muscles on reactive balance and gait performance in stroke participants. Methods: Twenty individuals with chronic str...

What is the current status of trial NCT04957355?

This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2021-05-15. Estimated completion is 2025-11-30.

What conditions does trial NCT04957355 study?

This clinical trial studies the following conditions: Chronic Stroke.

What interventions are being tested in trial NCT04957355?

The interventions under investigation include: Neuromuscular electrical stimulation (NMES) or Functional electrical stimulation (FES) (DEVICE).

Who is sponsoring clinical trial NCT04957355?

This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04957355 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04957355's enrollment target sits among peer trials

20 13th of 20 higher than 6 of 20 other Chronic Stroke trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Chronic Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00573339 · 20 participants

    Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04957355, the US trial registry maintained by the National Library of Medicine. NCT04957355 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.